Injections
- All
- News
- Videos
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
6 Hidden Health Risks In Fruits That You Need To Know
The fruits on your table have many hidden health risks. Here is a list of possible risks that may be involved in fruits that you need to know, and ways to be careful.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
"Used To Take Pills, Injections": Shoaib Akhtar's Admission On Playing vs India During Heights Of Rivalry
The likes of Wasim Akram, Waqar Younis, Shoaib Akhtar, and Saqlain Mushtaq could lift their game whenever they faced India
-
Free Medicine Programme For Haemophilia Patients Rolled Out In Karnataka
Karnataka government launched 'Kusuma Sanjeevini' programme under which patients suffering from haemophilia will be provided treatment at no cost.
-
Botox vs Fillers: Expert Shares Prices In India, Differences Between The Beauty Procedures
Dr Akanksha Agarwal explains how these popular procedures differ, who may consider them, costs in India, risks, and why informed consultation matters before opting for treatment.
-
Former Pakistan PM Imran Khan Receives Eye Treatment At Hospital
Pakistan's jailed former prime minister Imran Khan received eye treatment on Tuesday, according to a hospital statement, although a spokesman for the ex-cricket star complained he was not allowed to see his personal doctor.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
6 Hidden Health Risks In Fruits That You Need To Know
The fruits on your table have many hidden health risks. Here is a list of possible risks that may be involved in fruits that you need to know, and ways to be careful.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
"Used To Take Pills, Injections": Shoaib Akhtar's Admission On Playing vs India During Heights Of Rivalry
The likes of Wasim Akram, Waqar Younis, Shoaib Akhtar, and Saqlain Mushtaq could lift their game whenever they faced India
-
Free Medicine Programme For Haemophilia Patients Rolled Out In Karnataka
Karnataka government launched 'Kusuma Sanjeevini' programme under which patients suffering from haemophilia will be provided treatment at no cost.
-
Botox vs Fillers: Expert Shares Prices In India, Differences Between The Beauty Procedures
Dr Akanksha Agarwal explains how these popular procedures differ, who may consider them, costs in India, risks, and why informed consultation matters before opting for treatment.
-
Former Pakistan PM Imran Khan Receives Eye Treatment At Hospital
Pakistan's jailed former prime minister Imran Khan received eye treatment on Tuesday, according to a hospital statement, although a spokesman for the ex-cricket star complained he was not allowed to see his personal doctor.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
